Back to Agenda
Updates from the FDA
Speaker(s)
Peter Marks, MD, PHD
Senior Vice President, Molecule Discovery and Head of Infectious Disease, Eli Lilly and Company, United States
Updates from the FDA
Nicole Verdun, MD
Director, Office of Therapeutic Products, CBER, FDA, United States
Updates from the FDA
Have an account?